Current screening guidelines could miss prostate cancer in transgender women receiving estrogen

FHS
June 26, 2024
6:38 pm

Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.

Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition – Pharmaceutical Technology

Credit: MattLphotography/Shutterstock.com. Climate change’s escalating impact is reshaping the infectious disease landscape in pervasive and profound ways. Rising temperatures are expanding the reach of disease-carrying

November 28, 2024

The federal government fails to provide Americans with reproductive health information they need. Here’s a better approach

Soon after the end of Roe v. Wade, President Biden issued an executive order attempting to ensure access to reproductive health care services nationally. One

December 15, 2023

AI-driven ECG age prediction transforms early disease detection

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early detection of aging-related conditions like heart disease, Alzheimer’s, and cancer.

February 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.